Biogen Halves Price Of Alzheimer’s Drug To $28,200

Biogen Inc (BIIB.O) on Monday cut the price of its Alzheimer’s drug by about half to $28,200 for an average weight person after facing slower-than-expected U.S. sales on complaints from hospitals that its high cost was not worth its benefits. The U.S. Food and Drug Administration (FDA) approved the drug, Aduhelm, in June to treat the brain-wasting ...

Read More

Annual Employee Benefits Compliance Responsibilities On January 1st

Each year brings annual compliance responsibilities to employers regarding their health plans and federal Affordable Care Act (ACA) and COBRA responsibilities. It’s important for employers to be aware of – and adhere to – these responsibilities.

Read More

The ‘Real Miracle’: Nevada’s Roller-Coaster Rollout Of COVID-19 Vaccine

Over the past year, 1.6 million Nevadans — or about half of the state’s population — have been inoculated against COVID-19 in a roller-coaster rollout of the vaccine.

Read More

Nevada Implements Insurance Surcharge On Unvaccinated State Workers

Nevada has become the first state to implement a health care premium surcharge on some 5,000 state employees not vaccinated against COVID-19 starting in July 2022.

Read More

Nevada COVID Activity Rising, But Far Below 2020 Levels

Nevada’s coronavirus activity is inching up since the Thanksgiving holiday but remains only a fraction of what it was this time last year.

Read More

CMS Actuaries: Healthcare Expenditures Spiked 9.7% In 2020 Amid COVID-19 Response

U.S. healthcare spending skyrocketed in 2020 as the federal government invested significantly in response to the COVID-19 pandemic, according to new data from the Centers for Medicare & Medicaid Services (CMS). CMS’ Office of the Actuary released its annual report on health expenditures, which found spending increased by 9.7% in 2020 to reach $4.2 trillion. ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square